31 studies found for:    " February 14, 2007":" March 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Computer Assisted Rx Education for HIV-Positives: CARE+
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: CARE+
2 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
3 Unknown  Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Intervention: Behavioral: Prevention Care Advocate
4 Active, not recruiting A Phase 2 Study of the Safety of Ritonavir-Boosted Elvitegravir Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Elvitegravir;   Drug: Ritonavir;   Drug: ARV regimen
5 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
6 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
7 Completed Positive Choice: Prevention for Positive Health
Conditions: HIV Infections;   Sexual Risk Behavior;   Substance Use Risks
Intervention: Behavioral: Positive Choice
8 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
9 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
10 Completed HIV Prevention Among Substance Abusing SMI
Conditions: Mentally Ill Persons;   Substance Abuse;   HIV Infections
Intervention: Behavioral: PATH
11 Completed Enhancing Oral Health Care Use by HIV Positive Individuals
Conditions: Oral Health Care;   HIV Infections;   Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention
12 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
13 Completed Pharmacogenetics of Antiretroviral Drugs
Condition: HIV Infections
Intervention:
14 Completed
Has Results
Pioglitazone to Treat Fatty Liver in People With HIV Infection
Conditions: HIV Infections;   Hepatic Steatosis;   Insulin Resistance
Intervention: Drug: Pioglitazone
15 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
16 Completed Trial of Zinc and HIV Progression in Children
Condition: HIV Infections
Intervention: Dietary Supplement: Zinc
17 Completed Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
18 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
19 Completed Safety Study of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: Placebo gel;   Drug: UC 781
20 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years